Alzheimer's Disease And Dementia
In patients with mild Alzheimer's disease, solanezumab did not significantly reduce cognitive decline over time.
Positive beliefs about age may protect against dementia.
Depressive symptoms and apathy were independently associated with incident dementia in community-dwelling older adults.
In the United States, it is estimated that 15 million people will have clinical Alzheimer disease or mild cognitive impairment by 2060.
There is no significant risk of Alzheimer's disease or dementia for men getting androgen deprivation therapy.
Primary hyperparathyroidism may be linked to lower intracerebral vasomotor reactivity, which could lead to cognitive dysfunction.
Depressive symptoms and subjective memory complaint could be used as early detection markers of Alzheimer's disease.
Midlife vascular risk factors such as smoking, diabetes, and hypertension are linked to a higher risk for dementia.
People born in higher stroke mortality states seem to have more health issues including a higher risk of developing dementia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age